Alcohol Dehydrogenase Inhibitor Shortage Ends
The US Food and Drug Administration has announced an end to the shortage of Fomepizole Injection, which is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning. It can be used alone or in combination with hemodialysis, depending on patient circumstances. The drug works by catalyzing the initial steps in the metabolism of ethylene glycol and methanol to their other toxic metabolites (https://bit.ly/2miWDUj).
_________________________________________________________________________________________________________________________________________
RELATED CONTENT
Modified Antibiotics Can Kill Resistant Superbugs
More Pharmacist Involvement Can Reduce Hospital Costs and Improve Patient Care
_________________________________________________________________________________________________________________________________________
The shortage lasted almost two years, beginning on March 18, 2015 and ending on February 14, 2017.
|
Presentation |
National Drug Code |
Company |
|
1g/mL, 1.5 ml vial
|
39822-0710-1; X-Gen label
|
American Regent/Luitpold |
|
1g/mL, 1.5 ml vial
|
67457-211-02
|
Mylan Institutional |
--Sean McGuire
